vascuCAP vs KardiaPro
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
While both vascuCAP and KardiaPro are FDA-cleared AI tools in cardiology, they address different aspects of patient care. vascuCAP focuses on advanced CT angiography analysis for plaque characterization and cardiovascular risk stratification, aiding in treatment decisions for existing conditions. In contrast, KardiaPro is designed for remote patient monitoring of ECG, blood pressure, and weight data, utilizing AI for arrhythmia detection and supporting ongoing patient management between appointments.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
vascuCAP integrates with DICOM and offers PACS/EMR interoperability for seamless incorporation into radiology and cardiology workflows. KardiaPro is a web-based portal designed to support modern cardiovascular care workflows, integrating with AliveCor's personal ECG devices and offering EHR interoperability with appropriate SDK/API configurations, including direct integration with Epic through its App Orchard Marketplace.
vascuCAP's AI algorithms for plaque quantification and characterization are histologically validated, and studies have shown it significantly outperforms stenosis-based guidelines in predicting risk of major adverse neurological and cardiovascular events. KardiaPro utilizes FDA-cleared AI for arrhythmia detection, with studies showing its AFib detection algorithm has a 96.6% sensitivity and 94% specificity compared to expert cardiology over-read of 12-lead EKGs.
While specific details on vascuCAP's learning curve are not provided, KardiaPro offers user guides and support resources for its web-based portal and compatible devices. KardiaMobile devices, which integrate with KardiaPro, are designed for ease of use, with over 93% of patients finding them easy to use.
KardiaPro is SOC-2 certified and ISO 27001 certified, demonstrating adherence to stringent security standards beyond HIPAA. These certifications indicate a robust information security management system and strong controls over security, availability, processing integrity, confidentiality, and privacy.
KardiaPro has several case studies and guidance documents available, including those from NICE (National Institute for Health and Care Excellence) and studies on its impact within the AHSN environment. One study noted that KardiaMobile use allowed doctors to diagnose 56% of patients with palpitations or pre-syncope in 9.5 days on average, compared to 10% in 43 days with standard care, and could reduce costs by nearly $1,200 per treated patient.
KardiaPro's web-based portal allows for the management and review of patient data, and while specific audit trail features are not detailed in the provided information, it is SOC-2 certified, which typically includes controls around data integrity and logging. General audit trails in healthcare software usually capture new data submissions, edits, and the person responsible for the changes, along with timestamps.
More Comparisons
Backers
Who funded each tool's parent company.